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Introduction
Liver cirrhosis represents a consequence of progressive hepatic 
fibrosis from recurrent injury characterized by disruption of 
the hepatic architecture and the formation of irreversible 
regenerative nodules commonly identified on imaging. The 
most common causes in the United States are hepatitis C virus 
(HCV) cirrhosis, alcoholic cirrhosis, and nonalcoholic steato-
hepatitis (NASH) cirrhosis accounting for 53.5%. With the 
current trajectory of increasing obesity, NASH-related cirrho-
sis is projected to be the most prevalent cause in future years.1 
Cirrhosis is a major cause for hospital admissions, readmis-
sions, and financial expense and mortality. A study conducted 
in 2012 demonstrated that cirrhosis and its complications lead 
to more than 150 000 hospitalizations costing nearly US $4 bil-
lion each year.2 Liver cirrhosis is associated with a myriad of 
complications including cardiac, renal, immune, and neurologic 
dysfunctions.3 Patients with cirrhosis may also present with a 
diverse range of signs and symptoms that reflect the integral 
role that the liver has in the homeostasis of a multiple body 
functions.4,5 There have been several studies which demon-
strate that perioperative mortality is significantly higher in 
patients with cirrhosis undergoing surgery compared with the 
general population.6 Cirrhotic patients with high Child-Pugh 
score, low albumin, poor nutritional status, poor renal and/or 
cardiac function have usually a higher mortality7,8 among other 
cirrhotic patients. Many surgical procedures and its complica-
tions including wound infection, bleeding, length of study, and 
others parameters have been well studied in cirrhotic patients.9 
In the general population, the risks following appendectomy 
are as follows: surgical wound infection (4.0%), prolonged ileus 
(3.8%), deep wound infection (3.6%), systematic sepsis (1.2%), 
and prolonged bleeding requiring transfusion (0.4%).9,10,11 
There have been few, small-scale studies conducted to examine 
the complications and mortality rate associated with appen-
dectomy in cirrhotic patients. The surgical removal of an 
inflamed appendix is the most common surgical emergency 
worldwide. Although it has been over 100 years since Reginald 
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Heber Fitz characterized the typical presentation and patho-
physiology of appendicitis and appendectomy, appendicitis 
continues to present challenges for the surgeon today.12 
Appendectomies, in the United States, account for more than 
1 million hospital days per year. Our study examined the mor-
tality and complication rate associated with appendectomy in 
cirrhotic patients compared with the general population. The 
study has clearly shown that morality rate in cirrhotic patients 
is not higher than the general population and, therefore, should 
not be a contraindication for surgery.
Methods
The 2010 National Inpatient Sample (NIS) was used. The NIS 
is the largest all-payer inpatient care database containing 
around 8 million hospital stays from about 1000 hospitals in 
the United States. These data are collected as part of the 
Healthcare Cost and Utilization Project (HCUP) by the 
Agency for Healthcare Research and Quality (AHRQ). 
The NIS is designed to approximate a 20% sample of US non-
Federal hospitals, including public hospitals and academic 
medical centers assigned by the American Hospital Association.
Each hospital record includes a unique patient identifier, 
demographic data, admission type, primary and secondary 
diagnosis and procedures, primary and secondary insurance 
payers, length of stay including hospital charges, and hospital 
characteristics. Hospital geographic region was subcategorized 
into Northeast, Midwest, West, and South. The control/own-
ership of the hospitals was classified as government non-Fed-
eral (public), private not-for-profit (voluntary), and private 
investor-owned (proprietary).
Case and outcome variable identif ications
The International Classif ication of Diseases, Ninth Revision, 
Clinical Modification (ICD-9-CM) diagnostic codes are used 
to capture all admissions in the NIS data set with appendec-
tomy-related admission and has history of cirrhosis. 
International Classif ication of Diseases, Ninth Revision (ICD-9) 
code for laparoscopic appendectomy (4701) and ICD-9 code 
for cirrhosis (5710, 5712, 5713, 5715, 5716, and 5718) were 
used. The rest of the variables are already defined in the NIS 
data.
Statistical analysis and the study design
The primary outcome of the study is to examine the difference 
in the morbidity and mortality of laparoscopic appendectomy 
in people with cirrhosis vs noncirrhotic patients. Inclusion cri-
teria were all race and sex who are 18 years or older. Those who 
have laparoscopic appendectomy and have a history of liver cir-
rhosis were assigned to case group. An equal random number 
of appendectomy-related admissions and those who have no 
history of liver cirrhosis were selected and placed in the control 
group. Only laparoscopic appendectomy-related admission was 
included as it is the most commonly used procedure to remove 
the appendix these days. The procedure used in SPSS for 
selecting control group is called arbitrary random equivalent 
number. Case-control (appendectomy with history of cirrhosis 
vs appendectomy without cirrhosis) design is used.
Data were analyzed using the IBM SPSS version 24 statis-
tical software for Mac computer. Mean, percentages, and 
standard deviation of the mean were used to examine the 
demographic feature of the target population. Multivariate 
logistic regression statistical test is used to see whether there is 
any difference in mortality and morbidity in case vs control 
group (see Table 2). A confidence interval (CI) of 95% and P 
value less than .05 were determined to define the statistical dif-
ference between the 2 groups.
Results
A total of 754 appendectomy-related admissions were identi-
fied—376 appendectomy-related admissions and history of 
cirrhosis (case group) and 378 admissions with appendectomy 
and no history of cirrhosis (control group). Of 754, 520 were 
white (73.5%), 34 black (4.8%), 115 Hispanic (16.2%), 13 
Asians (1.8%), 4 Native American (0.6%), and others (3.1%). 
In all, 334 (44.3%) were men and 420 (55.7%) were women. 
The mean age was 43.75 years for the case group and 46.68 years 
for the control group (see Table 1).
Comparing cirrhotic with noncirrhotic group, the mean 
length of stay was 1.1 vs 1.52 days, inpatient mortality was 2 
(0.5%) vs 1 (0.3%), (P = .56, odds ratio [OR] = 2, 95% CI: 
0.18-22.3), pneumonia 8 (2.1%) vs 3 (0.8%) (P = .142, 
Table 1. Demography.
P vALUE NO 
CIRRHOSIS
HISTORY OF 
CIRRHOSIS
Mean age, y .54 43.75 46.68
Sex
 Male .55 131 (34.7%) 203 (54%)
 Female .65 247 (65.3%) 173 (46%)
 Total 378 (100%) 376 (100%)
Race
 White .05 313 (83.2%) 238 (63.5%)
  African 
American
.005 21 (5.6%) 15 (4%)
 Hispanic .006 23 (6.4%) 97 (26%)
 Asian .65 6 (1.7%) 7 (2%)
  Native 
American
0 (0.0%) 4 (1%)
 Others 11 (3.1%) 12 (3.1%)
 Total 378 (100%) 376 (100%)
Mean length 
of stay
1.1 1.52
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OR = 2.7, 95% CI: 2.7-10.32), surgical site infection 3 (0.8%) 
vs 2 (0.5%) (P = .652, OR = 1.52, 95% CI: 0.25-9.10), urinary 
tract infection (UTI) 18 (4.8%) vs 12 (3.2%) (P = .26, 
OR = 1.53, 95% CI: 0.72-3.22), postoperative bleeding 3 
(0.8%) vs 2 (0.5%) (P = .65, OR = 1.51, 95% CI: 0.25-9.1), 
pulmonary thromboembolism 1 (0.3%) vs 0 (0.0%) (P = .94, 
OR = 0, 95% CI: 0.03-0.8), Clostridium diff icile infection 1 
(0.3%) vs 0 (0.0%) (P = .99, OR = 0), upper gastrointestinal 
(GI) bleeding 3 (0.8%) vs 1 (0.3%) (P = .332, OR = 3, 95% CI: 
0.3-29) (Table 2).
Discussion
The increase in the prevalence of the NASH and the chronic 
HCV infection both contribute to the increase in the incidence 
and prevalence of cirrhosis in the United States. Accompanying 
that increase, the physicians and hospitals will be exposed to 
more medically complicated cirrhotic patients in addition to 
emergencies and elective surgeries. Acute appendicitis is one of 
the most common surgical emergencies in United States and it 
occurs in 7% of the general population with an incidence of 1.1 
cases per 1000 persons annually, whereas its incidence in cir-
rhotic population is not well studied.9
Appendectomy, laparoscopic approach or open laparotomy 
approach, is the standard of care in the management of patients 
with acute appendicitis and associated with low morbidity and 
mortality rate in the general population, whereas its morbidity 
and mortality in cirrhotic patients have yet to be sufficiently 
compiled. Although the nonsurgical approach with the admin-
istration of antibiotics is safer in the nonsurgically candidate 
patients, that approach was found to be associated with high 
rate of recurrence and peritonitis in an open-label randomized 
clinical study done in France by Vons et al10 in a cohort of 243 
patients. Very few studies examined the mortality and morbid-
ity of appendectomy in cirrhosis. Our study is the largest study 
focusing on the appendectomy in cirrhotic patients and deter-
mining the risk of postoperative complications, including 
wound infection, pneumonia, UTI, C diff icile–associated diar-
rhea (CDAD), GI bleeding, and length of stay in 376 patients, 
and comparing the result with noncirrhotic randomly selected 
controls.
Tsugawa et al12 compared the laparoscopic appendectomy 
with open appendectomy in 40 cirrhotic patients and found 
less wound infection, less wound bleeding, and shorter hospi-
tal stay in the laparoscopic appendectomy group. Puggioni 
et al reported that the risk of wound infection was 1.6% in his 
meta-analysis of cirrhotic patients who had laparoscopic 
cholecystectomy. That low incidence was also reported by the 
study by Ziser et  al, who reported that the risk of wound 
infection was low and representing 2.6% of his cohort. In our 
study, the risk of wound infection was lower than the pub-
lished data and was not different from the noncirrhotic group 
(control group) with percentages of 0.8% and 0.5%, respec-
tively (P = .65).13,14
Ziser et  al found that pneumonia was the most common 
postoperative complication in cirrhotic patients who under-
gone surgical procedure under anesthesia representing 8% of 
his cohort of 733 patients, whereas Georgiou et al found that 
the risk was higher in cirrhotic patients undergoing laparotomy 
operation in trauma patients with a percentage of 11%.13,15 In 
contrast, our data suggest that the risk of pneumonia is less 
than the suggested data with a percentage of 2.1% of the total 
cohort and it was not statistically significant from the control 
group with P value of .142.
Urinary tract infection represents 13% of all health care–
associated infections in the United States and is associated 
with an increase in the mortality rate. Tsugawa et al reported 
that 4% of the patients in his cohort developed UTIs. In con-
trast, our data showed that the risk of UTI is higher than what 
Tsugawa et al have reported and it was higher than the noncir-
rhotic group too. The risk of UTI was 4.8% in the cirrhosis 
group and 3.2% in the control group (P = 1.53).12
The risk of developing CDAD postoperatively in general 
population considered to be low and studies estimated the 
prevalence to be ranged between 0.5% and 1.2%, higher risk 
found in patients with hypoalbuminemia and immuno- 
suppression.16,17
Table 2. Logistic regression analysis of morbidities and mortalities.
MORBIDITY AND MORTALITY APPENDECTOMY AND 
CIRRHOSIS (379)
APPENDECTOMY AND 
NO CIRRHOSIS (378)
P vALUE OR (95% CI)
Mortality 2 (0.5%) 1 (0.3%) .56 2 (0.18-22.3)
Pneumonia 8 (2.1%) 3 (0.8%) .142 2.717 (0.71-10.32)
Surgical site infection 3 (0.8%) 2 (0.5%) .652 1.52 (0.25-9.10)
Urinary tract infection 18 (4.8%) 12 (3.2%) .26 1.53 (0.72-3.22)
Postoperative bleeding 3 (0.8%) 2 (0.5%) .65 1.51 (0.25-9.1)
Pulmonary thromboembolism 1 (0.3%) 0 (0.0%) .94 0 (0.03-0.8)
Clostridium difficile infection 1 (0.3%) 0 (0.0%) .99 0 (0.0-0.0)
Upper gastrointestinal bleeding 3 (0.8%) 1 (0.3%) .332 3.02 (0.3-29)
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In cirrhotic population, the risk of CDAD is higher than 
noncirrhotic secondary to 3 reasons: first, the usage of antibi-
otics in preventing infection and improving mortality espe-
cially quinolone which is known to be associated with a high 
risk of CDAD.18,19 Second, the use of proton pump inhibitor 
is more common in the cirrhotic population which is associ-
ated with high risk of developing CDAD.20 Third, the fre-
quent hospitalization carries high risk of developing CDAD.21 
Bajaj et al22 found in his retrospective study that CDAD has 
higher mortality when compared with noncirrhotic patients. 
Our cohort showed that only 1 patient (0.3%) had CDAD 
during his hospitalization for the appendectomy and none 
found in the noncirrhotic group.
Bleeding, upper GI bleeding and postoperative bleeding, was 
reported by Ziser et  al in their 733 cirrhotic patients. Ziser 
et al13 found that the percentage of GI bleeding and surgical 
bleeding was 4.6% and 4.9%, respectively. Our cohort showed 
that the risk of bleeding following appendectomy was very low. 
The percentages of postoperative bleeding and upper GI bleed-
ing were reported in our cohort as 0.8% and 0.8%, respectively.
The mortality rate in the general population is low and 
ranged between 1.8% and 1%, whereas the mortality rate in our 
cohort was low with percentages of 0.5% and 0.3%, respec-
tively, and not statistically significant between the 2 groups.23
Although our data do not show the severity of the cirrhosis 
and the level of the impairment of the liver function due to the 
lack of the ability to calculate the Model For End-Stage Liver 
Disease (MELD score) and Child-Pugh score, the findings 
showed that the risk of complication is not different between 
the 2 groups. Such findings could be explained by the general 
improvement in the sterile techniques, new high technology 
devices, and the increase in the surgical laparoscopic experience. 
Our study had certain limitations in that the NIS is a retrospec-
tive database using administrative ICD-9 codes, thus question-
ing the accuracy of coding procedures. Our data lack the 
information about the degree of cirrhosis and does not include 
MELD score or Child-Pugh score that is usually used to deter-
mine the severity of the disease. Our data do not include the 
synthetic function of the liver (albumin and international nor-
malized ratio), which affects the postoperative course. The 
platelet number is not included in our study which could affect 
and correlate with the risk of bleeding in the cirrhotic patients. 
Finally, there could be also a clerical error involved as the data-
base is taken from charts completed by humans, with human 
error, as well as completion of charts from many different insti-
tutions across the United States. Although several limitations 
may exist, we believe that these are counterbalanced by the large 
sample size and absence of reporting bias as in some publica-
tions from specialized centers or those with a financial interest.
Conclusions
Appendectomy in cirrhotic population is a safe procedure and 
does not have mortality and morbidity differences from non-
cirrhotic population.
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